Windlas Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 26	Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22

Sales

904.09

759.88

630.96

513.08

465.93

Operating profit

104.70

94.12

78.10

60.24

52.90

Interest

4.83

4.38

1.10

0.79

1.42

Gross profit

117.67

107.38

90.47

69.42

58.18

EPS (Rs)

31.48

28.94

27.96

20.38

17.69

Other income

17.80

17.65

13.47

9.97

6.71

Stock adjustment

7.10

-21.52

9.59

-15.27

-4.74

Raw material

550.13

493.38

386.59

340.71

307.56

Power and fuel

-

-

-

-

-

Employee expenses

152.09

122.92

87.46

70.32

63.41

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

90.07

70.99

69.22

57.07

46.81

Provisions made

-

-

-

-

-

Depreciation

30.74

27.99

13.44

12.36

12.15

Taxation

20.50

18.75

18.88

14.41

7.48

Net profit / loss

66.44

60.65

58.14

42.64

38.56

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.55

10.48

10.40

10.46

10.90

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.58

12.39

12.38

11.74

11.35

GPM (%)

12.76

13.81

14.04

13.27

12.31

NPM (%)

7.21

7.80

9.02

8.15

8.16